O. Caffo

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience (2009)

Galligioni, E., Berloffa, F., Caffo, O., Tonazzolli, G., Ambrosini, G., Valduga, F., ...

Background: We describe our experience with an electronic oncological patient record (EOPR) for the total management of cancer patients. Methods: The web-based EOPR was developed on the basis of a...

Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy (1996)

Pelosio, P., Barbareschi, M., Bonoldi, E., Marchetti, A., Verderio, P., Caffo, O., ...

Background: Experimental and clinical studies suggest that cyclin D1 is involved in transformation and tumour progression. However, there is little and contradictory data on the clinical significance...

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.

Barbareschi, M., Caffo, O., Doglioni, C., Fina, P., Marchetti, A., Buttitta, F., ...

p21 protein (p21) inhibitor of cyclin-dependent kinases is a critical downstream effector in the p53-specific pathway of growth control. p21 can also be induced by p53-independent pathways in...

Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up.

Mauri, F. A., Caffo, O., Veronese, S., Verderio, P., Boracchi, P., Bonzanini, M., ...

Carcinoembryonic antigen (CEA) is a well-known tumour marker whose immunohistochemical expression could be prognostically relevant in breast carcinomas. We evaluated CEA immunohistochemical...

A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

Gridelli, C, Gallo, C, Di Maio, M, Barletta, E, Illiano, A, Maione, P, ...